Posted in | News | Business | Photonics

USPTO Issues Patents to Intematix’ Phosphors for Lighting and Display Applications

Intematix Corporation, a leading manufacturer of phosphor solutions for LED lighting, today announced that patents covering its green and yellow GAL® phosphor products and certain LuAG phosphors have been issued by the United States Patent and Trademark Office.

Patent numbers 8,529,791 and 8,475,683 regarding green and yellow emitting, garnet-based phosphors used in lighting and display applications were issued on September 10, 2013 and July 2, 2013, respectively. Intematix GAL phosphors enable exceptional performance for LED lighting compared to other options in these color ranges.

GAL phosphors’ light emission characteristics result in higher Color Rendering Index (CRI) in LED lighting applications. When combined with red nitride or other red phosphors, arrangements also covered by these patents, CRIs up to 98 (out of 100) have been demonstrated.

“By using our GAL phosphors, LED solutions may be designed for efficient performance at CRIs greater than 90,” said Yi-Qun Li, Chief Technology Officer at Intematix. “This technology is instrumental to meeting new standards like California’s Quality LED Lamp Specification.”

GAL phosphors also provide up to 95% lumen maintenance at 200°C phosphor temperature, enabling LEDs of all types, including mid-power LEDs, to operate at higher output and efficacy. The products are also versatile design tools for LEDs used in displays like TVs and tablets.

For more information on Intematix phosphors and intellectual property please visit www.intematix.com.

Source: http://www.intematix.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.